Actions & Insights Evaluating a Novel Diabetes Management Solution

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

163 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-17

Study Completion Date

2018-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single visit outcome study to obtain qualitative and quantitative data for a new BGMS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Active Health-Based Comprehensive Study on Diabetes Management

NCT07160998

Diabetes

COMPLETED NA

Evaluation of a Diabetes Data Management System

NCT00694070

Diabetes

COMPLETED

A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.

NCT02156349

Type II Diabetes Mellitus

COMPLETED NA

Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences

NCT02429024

Diabetes Mellitus

COMPLETED PHASE4

The Effect of Share Care Model in the Improvement of Diabetes Management

NCT03707379

Diabetes Mellitus, Type 2

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During ASCEND, patients will complete a single visit clinical study divided into two distinct parts. Part 1 involves each subject completing a number of simple quantitative exercises to gauge their level of comprehension of diabetes related information. Subjects will then continue during the same visit to complete part 2 which involves gathering qualitative feedback from each subject on the new Blood glucose monitoring system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus ( Type 1 and Type 2)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with T1DM or T2DM
* Performs SMBG
* Male or female, at least 16 years old.
* Able to communicate (speak, read and write) in English
* Willing to sign an informed consent.

Exclusion Criteria

* Unlikely to be compliant with the study in the opinion of study staff.
* Conflict of Interest - Prospective Participants are currently working for, previously worked for, or have an immediate family member currently working for a company that manufactures or markets the products tested under this procedure

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No